BiotechTube
Home/Pipeline/CBD for Graft‑Versus‑Host Disease

CBD for Graft‑Versus‑Host Disease

GVHD

Phase 2Active

Key Facts

Indication
GVHD
Phase
Phase 2
Status
Active
Company
Stero Biotechs

About Stero Biotechs

CBD‑driven steroid‑sparing therapies for inflammatory and autoimmune diseases.

View full company profile

Therapeutic Areas

ImmunologyInflammatory diseasesGastroenterologyDermatologyInfectious diseases